Overview
Matilde Garcia-Ruiz practices practicing medicine in Mexico City, Mexico.
Ms. Garcia-Ruiz is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), Mucopolysaccharidoses (MPS), ALG1-CDG, and Anti-NMDA Receptor Encephalitis.
She is actively involved in clinical research, co-authoring 24 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Matilde G. Garcia-Ruiz
Is Matilde G. Garcia-Ruiz a top-rated expert for Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome)?
MediFind is an objective health platform that identifies experts based on real-world data. Matilde G. Garcia-Ruiz is classified as an Elite expert for Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Matilde G. Garcia-Ruiz participate in research or clinical trials?
Yes. Matilde G. Garcia-Ruiz has published 24 articles and abstracts on conditions like Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome). You can view a list of Matilde G. Garcia-Ruiz's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome)
- Distinguished
- ALG1-CDGMs. Garcia-Ruiz isDistinguished. Learn about ALG1-CDG.
- Mucopolysaccharidoses (MPS)Ms. Garcia-Ruiz isDistinguished. Learn about Mucopolysaccharidoses (MPS).
- Experienced
- Anti-NMDA Receptor EncephalitisMs. Garcia-Ruiz isExperienced. Learn about Anti-NMDA Receptor Encephalitis.
- DystrophinopathyMs. Garcia-Ruiz isExperienced. Learn about Dystrophinopathy.
- EncephalitisMs. Garcia-Ruiz isExperienced. Learn about Encephalitis.
- EpilepsyMs. Garcia-Ruiz isExperienced. Learn about Epilepsy.
- Generalized Tonic-Clonic SeizureMs. Garcia-Ruiz isExperienced. Learn about Generalized Tonic-Clonic Seizure.
- Multiple Sulfatase DeficiencyMs. Garcia-Ruiz isExperienced. Learn about Multiple Sulfatase Deficiency.
- RhabdomyolysisMs. Garcia-Ruiz isExperienced. Learn about Rhabdomyolysis.
- SeizuresMs. Garcia-Ruiz isExperienced. Learn about Seizures.
- Teratoma of the MediastinumMs. Garcia-Ruiz isExperienced. Learn about Teratoma of the Mediastinum.